Matthew McManus's Net Worth
$900 Thousand
Who is Matthew McManus?
Matthew McManus does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Azenta, Inc., and BIO-TECHNE Corp.
SEC CIK
Matthew McManus's CIK is 0001908268
Past Insider Trading and Trends
2024 was Matthew McManus's most active year for acquiring shares with 7 total transactions. Matthew McManus's most active month to acquire stocks was the month of January. 2022 saw Matthew McManus paying a total of $501,543.75 for 8,625 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Azenta, Inc. (AZTA) Snapshot price: $47.57
EVP & Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.38% | 8.63K |
$58.15 | $501,543.75 | 29.47K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIO-TECHNE Corp (TECH) Snapshot price: $71.49
President - DGS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||